ARALEZ PHARMACEUTICALS INC. Operating Expenses
ARALEZ PHARMACEUTICALS INC. reported Operating Expenses of $61.23 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2018-03-14
- ARALEZ PHARMACEUTICALS INC. operating expenses for the quarter ending 2017-12-31 was $61.23M, a 33.97% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. operating expenses for the quarter ending 2017-09-30 was $38.73M, a 29.52% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. operating expenses for the quarter ending 2017-06-30 was $45.09M, a 71.19% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. operating expenses for the quarter ending 2017-03-31 was $43.90M, a 1.75% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $61.23M 10-K · filed 2018-03-14 | $99.96M derived: sum of 2 quarters · filed 2018-03-14 | $145.05M derived: sum of 3 quarters · filed 2018-03-14 | $188.94M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2017-09-30 | $38.73M 10-K · filed 2018-03-14 | $83.81M derived: sum of 2 quarters · filed 2018-03-14 | $127.71M derived: sum of 3 quarters · filed 2018-03-14 | $173.42M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2017-06-30 | $45.09M 10-K · filed 2018-03-14 | $88.99M derived: sum of 2 quarters · filed 2018-03-14 | $134.69M derived: sum of 3 quarters · filed 2018-03-14 | $164.59M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2017-03-31 | $43.90M 10-K · filed 2018-03-14 | $89.60M derived: sum of 2 quarters · filed 2018-03-14 | $119.50M derived: sum of 3 quarters · filed 2018-03-14 | $145.84M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-12-31 | $45.71M 10-K · filed 2018-03-14 | $75.61M derived: sum of 2 quarters · filed 2018-03-14 | $101.95M derived: sum of 3 quarters · filed 2018-03-14 | $145.09M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-09-30 | $29.90M 10-K · filed 2018-03-14 | $33.26M 10-Q · filed 2016-11-08 | $56.24M derived: sum of 2 quarters · filed 2018-03-14 | $108.64M 10-Q · filed 2016-11-08 | $119.48M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $26.34M 10-K · filed 2018-03-14 | $29.70M 10-Q · filed 2016-08-09 | $75.38M 10-Q · filed 2016-08-09 | $89.58M derived: sum of 3 quarters · filed 2018-03-14 | $103.60M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $43.14M 10-K · filed 2018-03-14 | $45.68M 10-Q · filed 2016-05-10 | $63.25M derived: sum of 2 quarters · filed 2018-03-14 | $77.26M derived: sum of 3 quarters · filed 2018-03-14 | $97.75M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $20.10M 10-K · filed 2017-03-13 | $34.12M derived: sum of 2 quarters · filed 2017-03-13 | $54.61M derived: sum of 3 quarters · filed 2017-03-13 | $58.86M derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-09-30 | $14.01M 10-K · filed 2017-03-13 | $34.51M derived: sum of 2 quarters · filed 2017-03-13 | $38.75M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | $20.50M 10-K · filed 2017-03-13 | $24.74M 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $4.25M 10-K · filed 2017-03-13 |